Compare · EW vs WLFC
EW vs WLFC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Willis Lease Finance Corporation (WLFC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while WLFC operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $61.61B, about 58.7x WLFC ($1.05B).
- EW has been more active in the news (12 items in the past 4 weeks vs 9 for WLFC).
- EW has more recent analyst coverage (25 ratings vs 1 for WLFC).
- Company
- Edwards Lifesciences Corporation
- Willis Lease Finance Corporation
- Price
- -
- -
- Market cap
- $61.61B
- $1.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 1996
- News (4w)
- 12
- 9
- Recent ratings
- 25
- 1
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Willis Lease Finance Corporation
Willis Lease Finance Corporation operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. The company operates through two segments, Leasing and Related Operations, and Spare Parts Sales. The Leasing and Related Operations segment engages in acquiring and leasing commercial aircraft, aircraft engines, and other aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and other related businesses. The Spare Parts Sales segment purchases and resells after-market engine parts, whole engines, engine modules, and portable aircraft components. Willis Lease Finance Corporation was founded in 1985 and is headquartered in Coconut Creek, Florida.
Latest EW
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 101 shares, decreasing direct ownership by 0.69% to 14,606 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $64,531 worth of shares (619 units at $104.25) as part of a pre-agreed trading plan (SEC Form 4)
- CEO Zovighian Bernard J exercised 23,100 shares at a strike of $72.68 and sold $2,379,779 worth of shares (23,100 units at $103.02) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr exercised 48,900 shares at a strike of $72.68 and sold $5,039,311 worth of shares (48,900 units at $103.05) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 22,798 units (SEC Form 4)
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
- Edwards Lifesciences upgraded by Robert W. Baird with a new price target
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Third Quarter Results
- Edwards Lifesciences upgraded by Truist with a new price target
Latest WLFC
- SEC Form DEF 14A filed by Willis Lease Finance Corporation
- SEC Form 10-Q filed by Willis Lease Finance Corporation
- Willis Lease Finance Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Willis Lease Finance Corporation Reports Solid Third Quarter 2026 Financial Results with Record Revenues and Income From Investments
- Willis Lease Finance Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Willis Lease Finance Corporation Declares Fourth Quarter 2026 Dividend and Renewal and Increase of Share Repurchase Plan
- SEC Form PRE 14A filed by Willis Lease Finance Corporation
- SEC Form 8-K filed by Willis Lease Finance Corporation
- Willis Lease Finance Corporation Announces Timing of Third Quarter 2026 Financial Results and Conference Call
- SVP, GC & Corporate Secretary Dameron Clifton covered exercise/tax liability with 1,420 shares, decreasing direct ownership by 4% to 38,038 units (SEC Form 4) (for tax liability)